BrightSpring Health Services Common StockNASDAQ: BTSG

LOUISVILLE, Ky., Nov. 06, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services (“BrightSpring” or “BrightSpring Health Services”) (NASDAQ: BTSG) is proud that CareMed, a BrightSpring company and leading independent Specialty Pharmacy, was selected by Eisai to be the national specialty pharmacy provider for Leqembi®, a cutting-edge treatment for Alzheimer's disease.

BrightSpring Health Services, Inc. (NASDAQ:BTSG ) Q3 2024 Earnings Conference Call November 1, 2024 8:30 AM ET Company Participants Jennifer Phipps - Chief Accounting Officer Jon Rousseau - President & Chief Executive Officer Jim Mattingly - Chief Financial Officer Conference Call Participants Brian Tanquilut - Jefferies A.J. Rice - UBS David Larsen - BTIG Joanna Gajuk - Bank of America Ann Hynes - Mizuho Securities Whit Mayo - Leerink Linda Bolduc - Morgan Stanley Jamie Perse - Goldman Sachs Pito Chickering - Deutsche Bank Matthew Gillmor - KeyBanc Capital Markets Operator Good day and thank you for standing by.

LOUISVILLE, Ky., Nov. 01, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG), a leading provider of home and community-based health services for complex populations, today announced financial results for the third quarter ended September 30, 2024, and increases 2024 revenue and Adjusted EBITDA1 guidance.

On September 30, 2024, FMR LLC (Trades, Portfolio) made a significant addition to its investment portfolio by acquiring 18,498,153 shares of BrightSpring Health Services Inc (BTSG, Financial). This transaction, executed at a price of $14.68 per share, reflects a strategic move by the firm, aligning with its broader investment objectives.

LOUISVILLE, Ky., Oct. 01, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that it plans to release its third quarter 2024 financial results on Friday, November 1, 2024, prior to the Company's earnings conference call, which will be held at 8:30 a.m. ET on the same day.

LOUISVILLE, Ky., Sept. 30, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services (“BrightSpring” or “the Company”) (NASDAQ: BTSG), a leading provider of home- and community-based health services for complex populations, today announced that Dr. Steve Miller was appointed as a Class II member of the Board of Directors. Dr. Miller will also serve as a member of the Board's Audit Committee and as the chair of the Board's Quality & Compliance and Governance Committee.

NEW YORK, NY / ACCESSWIRE / September 18, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of BrightSpring Health Services, Inc. ("BrightSpring Health Services, Inc.") (NASDAQ:BTSG) concerning possible violations of federal securities laws. BrightSpring conducted its initial public offering ("IPO") of 53,333,334 shares of common stock priced at $13.00 per share on or around January 25, 2024.

NEW YORK, NY / ACCESSWIRE / September 17, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of BrightSpring Health Services, Inc. ("BrightSpring Health Services, Inc.") (NASDAQ:BTSG) concerning possible violations of federal securities laws. BrightSpring conducted its initial public offering ("IPO") of 53,333,334 shares of common stock priced at $13.00 per share on or around January 25, 2024.

NEW YORK, NY / ACCESSWIRE / September 16, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of BrightSpring Health Services, Inc. ("BrightSpring Health Services, Inc.") (NASDAQ:BTSG) concerning possible violations of federal securities laws. BrightSpring conducted its initial public offering ("IPO") of 53,333,334 shares of common stock priced at $13.00 per share on or around January 25, 2024.